We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-7.92%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$8.14B
AUM Growth
+$473M
Cap. Flow
+$1.3B
Cap. Flow %
15.91%
Top 10 Hldgs %
18.35%
Holding
1,253
New
376
Increased
261
Reduced
225
Closed
366

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$180M
2
ZTS icon
Zoetis
ZTS
+$103M
3
GILD icon
Gilead Sciences
GILD
+$98.1M
4
SHW icon
Sherwin-Williams
SHW
+$85.9M
5
VZ icon
Verizon
VZ
+$79.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.21%
2 Financials 15.39%
3 Communication Services 14.58%
4 Consumer Discretionary 9.63%
5 Industrials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YELP icon
1076
Yelp
YELP
$1.41B
-8,285
Closed -$356K
UCB
1077
United Community Banks
UCB
$4.28B
-117,054
Closed -$2.44M
AAMI
1078
Acadian Asset Management
AAMI
$3.19B
-63,019
Closed -$1.12M
VIRX
1079
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-155
Closed -$98K
CTLT
1080
DELISTED
CATALENT, INC.
CTLT
-70,802
Closed -$2.08M
AY
1081
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
-87,350
Closed -$2.74M
EGRX
1082
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-47,509
Closed -$3.84M
CONN
1083
DELISTED
Conn's Inc.
CONN
-66,158
Closed -$2.63M
SLCA
1084
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-59,215
Closed -$1.74M
HOLI
1085
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
-58,461
Closed -$1.41M
MTBL
1086
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
-15,641
Closed -$89K
NXGN
1087
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-14,867
Closed -$246K
QUOT
1088
DELISTED
Quotient Technology Inc
QUOT
-35,745
Closed -$386K
UNVR
1089
DELISTED
Univar Solutions Inc.
UNVR
-540,980
Closed -$14.1M
CSII
1090
DELISTED
Cardiovascular Systems, Inc.
CSII
-33,074
Closed -$875K
UMPQ
1091
DELISTED
Umpqua Holdings Corp
UMPQ
-269,411
Closed -$4.85M
VIVO
1092
DELISTED
Meridian Bioscience Inc
VIVO
-75,021
Closed -$1.4M
OTIC
1093
DELISTED
Otonomy, Inc.
OTIC
-60,930
Closed -$1.4M
AMPE
1094
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-130
Closed -$92K
EMWP
1095
DELISTED
Eros Media World PLC
EMWP
-401
Closed -$202K
SREV
1096
DELISTED
ServiceSource International, Inc.
SREV
-23,615
Closed -$129K
CDK
1097
DELISTED
CDK Global, Inc.
CDK
-72,276
Closed -$3.9M
COHR
1098
DELISTED
Coherent Inc
COHR
-4,801
Closed -$305K
TVTY
1099
DELISTED
Tivity Health, Inc. Common Stock
TVTY
-200,190
Closed -$2.4M
ISBC
1100
DELISTED
Investors Bancorp, Inc.
ISBC
-31,598
Closed -$389K

Similar funds

Marshall Wace's Q3 2015 Portfolio in Review

As of Q3 2015, Marshall Wace held 1,253 positions worth $8.14B, up 6.2% from $7.67B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace deployed $1.3B of net new capital in Q3 2015, opening 376 new positions and adding to 261 existing holdings. Its largest new stake was Alphabet (Google) Class A: 5,575,920 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $137M trimmed.

  • Marshall Wace's largest Q3 2015 buy was Alphabet (Google) Class A: 5,575,920 shares worth $178M.
  • Marshall Wace added most to Zoetis in Q3 2015, an estimated $103M increase.
  • Marshall Wace's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $137M.
  • Marshall Wace fully exited Emerson Electric in Q3 2015, selling an estimated $46.3M.
  • Marshall Wace's ten largest holdings make up 18% of its $8.14B portfolio in Q3 2015.
  • Marshall Wace opened 376 new positions and closed 366 in Q3 2015.
  • Marshall Wace's portfolio value rose 6.2% quarter-over-quarter to $8.14B.

Based on Marshall Wace's 13F filing for Q3 2015, filed 12 Nov 2015.